Growth Metrics

Ultragenyx Pharmaceutical (RARE) Cash from Operations Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn -18.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.67%
Dec 31, 2025 -25.86%
Sep 30, 2025 -36.46%
Jun 30, 2025 -41.30%
Mar 31, 2025 12.96%
Dec 31, 2024 5.69%
Sep 30, 2024 43.16%
Jun 30, 2024 33.74%
Mar 31, 2024 -21.59%
Dec 31, 2023 6.91%
Sep 30, 2023 -23.63%
Jun 30, 2023 -50.36%
Mar 31, 2023 -33.48%
Dec 31, 2022 -66.24%
Sep 30, 2022 -59.84%
Jun 30, 2022 -18.21%
Mar 31, 2022 26.25%
Dec 31, 2021 12.98%
Sep 30, 2021 3.74%
Jun 30, 2021 -174.82%
Mar 31, 2021 -67.46%
Dec 31, 2020 13.31%
Sep 30, 2020 29.99%
Jun 30, 2020 198.08%
Mar 31, 2020 0.65%
Dec 31, 2019 -28.98%
Sep 30, 2019 -27.98%
Jun 30, 2019 -17.07%
Mar 31, 2019 -7.04%
Dec 31, 2018 31.74%
Sep 30, 2018 -11.56%
Jun 30, 2018 -55.83%
Mar 31, 2018 -46.19%
Dec 31, 2017 -71.61%
Sep 30, 2017 -115.67%
Jun 30, 2017 -23.12%
Mar 31, 2017 -36.33%
Dec 31, 2016 -17.89%
Sep 30, 2016 6.07%
Jun 30, 2016 -129.58%
Mar 31, 2016 -154.23%
Dec 31, 2015 -224.75%
Sep 30, 2015 -177.43%
Jun 30, 2015 -64.05%
Mar 31, 2015 -66.26%
Dec 31, 2014 -27.43%
Sep 30, 2014 -63.48%
Jun 30, 2014 -25.54%
Mar 31, 2014 -68.77%